Posts in Category: Regenerative Medicine

Why Traditional Implementation Methods Are Limiting Stem Cell Technologies.

The Lung Institute is one of the leading research institutions in the U.S that aims to provide regenerative cell solutions for lung diseases such as chronic bronchitis, emphysema, interstitial lung disease, and pulmonary fibrosis.

It was formed in 2013 in Tampa, Florida, but currently has other clinics in Dallas, Nashville, Pittsburg, and Scottsdale. Along with the diagnosis and treatment of lung disorders, the Lung Institute also provides treatment for disorders of the chest wall, and the esophagus.

With over a century of combined experience in the medical field, the Lung Institute offers a diverse staff of professionals in medical oncology, radiation oncology, pulmonary medicine, radiology, and surgery.

This team aims to improve the quality of life for their patients by introducing the successful implementation of minimally invasive therapies. The stem cell treatments offered, address the advancement of the disease and not just the suppression of symptoms, which are accompanied by adverse side effects.

According to cedars-sinai , the clinics also offer treatments ranging from blood treatments to bone marrow treatments. The goal is to reintroduce blood samples with a high concentration of stem cells back into the patient’s body. This will effectively kick-start the healing process.

Jack Coleman, Jr., the Senior Medical Director of the Lung Institute forwards that in the U.S, the way in which new medicines are introduced will limit the growth and development of stem cell technologies.

In a world where stem cell technologies are transforming the field of medicine, the traditional process is too slow. The process of getting approvals for clinical testing and treatments, to the treatment being made available, is long and littered with bureaucratic red tape.

The research into stem cell technologies is funded by large biotechnology firms or the government. Also, the industry regulatory agencies are under the control of the government.

This means that most of the costs will be transferred to the patients, as the firms and government try to recover investments. This will drive the patients to search for treatments that are less inhibited.

In late 2016, Jack Coleman, Jr. was invited to speak at the Third International Congress on Responsible Stem Cell Research, in Italy. This event is held annually to discuss modern stem cell application methods.

Jack Coleman, Jr. states that to contribute to the development of the safest and most suitable treatments to patients, it is necessary for healthcare development to be a global effort. To read patients’ testimonials, visit

Read related article: